F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response

This study has been terminated.

First Received: September 13, 2005 Last Updated: August 25, 2009 History of Changes

Sponsor:	Dresden University of Technology
Collaborator:	Advanced Biochemical Compounds GmbH
Information provided by:	Dresden University of Technology
ClinicalTrials.gov Identifier:	NCT00180193

Purpose

The purpose of this study is to monitor the amino acid uptake of brain tumors, before and during radiotherapy, with positron emission tomography.

Condition	Phase
Brain Tumor	Phase II

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response

Resource links provided by NLM:

MedlinePlus related topics: Brain Cancer Cancer

Further study details as provided by Dresden University of Technology:

Estimated Enrollment:	40
Study Start Date:	December 2003

Eligibility

Study Population

OMFD-PET of all patients after subtotal resection or biopsy of malignant glioma was evaluated.

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00180193

Locations

Germany
Department of Nuclear Medicine
Dresden, Germany, 01307

Sponsors and Collaborators

Dresden University of Technology

Advanced Biochemical Compounds GmbH

Investigators

Principal Investigator:

Joerg Kotzerke, MD

Department of Nuclear Medicine

More Information

No publications provided

Responsible Party:	Klinik und Poliklinik für Nuklearmedizin ( Prof. Dr. med. Jörg Kotzerke )
Study ID Numbers:	ABX-OMFD-FU
Study First Received:	September 13, 2005
Last Updated:	August 25, 2009
ClinicalTrials.gov Identifier:	NCT00180193 History of Changes
Health Authority:	Germany: Federal Office for Radiation Protection

Keywords provided by Dresden University of Technology:

Radiotherapy
F-18-OMFD

Additional relevant MeSH terms:

Brain Neoplasms
Neoplasms
Neoplasms by Site
Nervous System Diseases

Central Nervous System Diseases
Central Nervous System Neoplasms
Brain Diseases
Nervous System Neoplasms

ClinicalTrials.gov processed this record on February 08, 2010